Orca1

FDA inspection

McNeil PPC Inc.: FDA inspection ending Feb 5, 2002

FDA inspection 205389 · Voluntary Action Indicated (VAI) · Parsippany, NJ

Key facts

Inspection ID 205389
Firm McNeil PPC Inc.
FEI number 2211583
Address 100 Jefferson Rd
City Parsippany
State NJ
ZIP 07054
Fiscal year 2002
Inspection end date Feb 5, 2002
Classification Voluntary Action Indicated (VAI)
Project area Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices|New Drug Evaluation|Postmarket Assurance: Med Devices
Product type Devices, Drugs

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • Yes Establishment inspection report (EIR) exists
  • 10–99 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

Other inspections at this establishment

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections